Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |